The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Aflac removed two risks from its 2024 10-K: one addressing investment portfolio concentration by single-issuer or sector, and another covering major public health issues including COVID-19. The company modified five existing risks, with substantive changes to disclosures on global capital market conditions, interest rate risk exposure, regulatory impacts on profitability, and business concentration, while maintaining 22 risks unchanged and adding no new risk factors.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🔴 No Match in Current Filing
The concentration of the Company's investment portfolios in any particular single-issuer or sector of the economy may have an adverse effect on the Company's financial position or results of operations.
🔒
🔴 No Match in Current Filing
Major public health issues, including COVID-19 and any resulting or coincidental economic effects, could have an adverse impact on the Company's financial condition and results of operations and other aspects of its business.
🔒
🟡 Modified
Difficult conditions in global capital markets and the economy could have a material adverse effect on the Company's investments, capital position, revenue, profitability, and liquidity and harm the Company's business.
🔒
🟡 Modified
The Company is exposed to significant interest rate risk, which may adversely affect its results of operations, financial condition and liquidity.
🔒
🟡 Modified
Extensive regulation and changes in legislation can impact profitability and growth.
🔒
🟡 Modified
The Company's concentration of business in Japan poses risks to its operations and financial condition.
🔒
🟡 Modified
Catastrophic events, including those as a result of climate change or major public health issues, could adversely affect the Company's financial condition and results of operations as well as the availability of the Company’s infrastructure and systems.
🔒